BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21990651)

  • 21. Heparin induced thrombocytopenia.
    Gupta S; Gupta MM
    J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heparin-induced thrombocytopenia. Diagnosis, clinical course and therapeutic alternatives].
    Scheffold N; Maitra R; Cyran J
    Schweiz Med Wochenschr; 1998 Apr; 128(16):609-15. PubMed ID: 9611303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.
    Alving BM; Krishnamurti C
    Semin Thromb Hemost; 1997; 23(6):569-74. PubMed ID: 9469632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-induced thrombocytopenia.
    Chong BH; Chong JJ
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.
    Greinacher A; Warkentin TE
    Thromb Res; 2006; 118(2):165-76. PubMed ID: 16139874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues.
    Blackmer AB; Oertel MD; Valgus JM
    Ann Pharmacother; 2009 Oct; 43(10):1636-46. PubMed ID: 19737996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Selleng S; Greinacher A
    Semin Thromb Hemost; 2008 Jul; 34(5):425-38. PubMed ID: 18956282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia.
    Efird LE; Kockler DR
    Ann Pharmacother; 2006; 40(7-8):1383-7. PubMed ID: 16788093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia (an overview).
    Daneschvar HL; Daw H
    Int J Clin Pract; 2007 Jan; 61(1):130-7. PubMed ID: 16836645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
    Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
    Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital.
    Sturtevant JM; Pillans PI; Mackenzie F; Gibbs HH
    Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.
    Joseph J; Rabbolini D; Enjeti AK; Favaloro E; Kopp MC; McRae S; Pasalic L; Tan CW; Ward CM; Chong BH
    Med J Aust; 2019 Jun; 210(11):509-516. PubMed ID: 31155728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in diagnosis and treatment of heparin-induced thrombocytopenia.
    Lubenow N
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):407-12. PubMed ID: 15692252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Croatian Society for Haematology and Transfusion Medicine Guidelines on the diagnosis and management of heparin induced thrombocytopenia (HIT)].
    Bosnjak B; Culjak-Aleksić M; Gojceta K; Golubić-Cepulić B; Debeljak Z; Dodig J; Kogler-Majerić V; Mesarić J; Peraica-Planinc A; Princić M; Rode B; Skorić B; Stancic V; Suvić-Krizanić V; Sturm D; Tomicić M;
    Lijec Vjesn; 2012; 134(9-10):253-8. PubMed ID: 23297508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia.
    Brieger DB; Mak KH; Kottke-Marchant K; Topol EJ
    J Am Coll Cardiol; 1998 Jun; 31(7):1449-59. PubMed ID: 9626819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia: pathophysiology and new treatment options.
    Harenberg J; Jörg I; Fenyvesi T
    Pathophysiol Haemost Thromb; 2002; 32(5-6):289-94. PubMed ID: 13679659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of heparin-induced thrombocytopenia.
    Spinler SA; Dager W
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S5-11. PubMed ID: 14593977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.